Literature DB >> 7507336

Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis.

B Cheng1, S Christakos, M P Mattson.   

Abstract

Emerging data indicate that neurotrophic factors and cytokines utilize similar signal transduction mechanisms. Although neurotrophic factors can protect CNS neurons against a variety of insults, the role of cytokines in the injury response is unclear. We now report that TNF beta and TNF alpha (1-100 ng/ml) can protect cultured embryonic rat hippocampal, septal, and cortical neurons against glucose deprivation-induced injury and excitatory amino acid toxicity. The elevation of intracellular calcium concentration ([Ca2+]i) induced by glucose deprivation, glutamate, NMDA, or AMPA was attenuated in neurons pretreated with TNF beta. The mechanism whereby TNFs stabilize [Ca2+]i may involve regulation of the expression of proteins involved in maintaining [Ca2+]i homeostasis, since both TNF beta and TNF alpha caused a 4- to 8-fold increase in the number of neurons expressing the calcium-binding protein calbindin-D28k. These data suggest a neuroprotective role for TNFs in the brain's response to injury.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7507336     DOI: 10.1016/0896-6273(94)90159-7

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  139 in total

1.  Inhibition of NF-kappaB potentiates amyloid beta-mediated neuronal apoptosis.

Authors:  B Kaltschmidt; M Uherek; H Wellmann; B Volk; C Kaltschmidt
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

2.  CREB and NF-kappaB transcription factors regulate sensitivity to excitotoxic and oxidative stress induced neuronal cell death.

Authors:  Jian Zou; Fulton Crews
Journal:  Cell Mol Neurobiol       Date:  2006-04-22       Impact factor: 5.046

3.  Bidirectional concentration-dependent effects of tumor necrosis factor alpha in Shigella dysenteriae-related seizures.

Authors:  Yael Yuhas; Abraham Weizman; Shai Ashkenazi
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

Review 4.  Excitotoxic and excitoprotective mechanisms: abundant targets for the prevention and treatment of neurodegenerative disorders.

Authors:  Mark P Mattson
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 3.843

5.  Differential activation of tumor necrosis factor receptors distinguishes between brains from Alzheimer's disease and non-demented patients.

Authors:  Xin Cheng; Libang Yang; Ping He; Rena Li; Yong Shen
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

6.  Ablation of TNF-RI/RII expression in Alzheimer's disease mice leads to an unexpected enhancement of pathology: implications for chronic pan-TNF-α suppressive therapeutic strategies in the brain.

Authors:  Sara L Montgomery; Michael A Mastrangelo; Diala Habib; Wade C Narrow; Sara A Knowlden; Terry W Wright; William J Bowers
Journal:  Am J Pathol       Date:  2011-08-09       Impact factor: 4.307

Review 7.  Glutamate and neurotrophic factors in neuronal plasticity and disease.

Authors:  Mark P Mattson
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

8.  TNF-alpha and TNF-beta gene polymorphisms in cerebral infarction.

Authors:  Jae-Young Um; Neeon-Hyung An; Hyung-Min Kim
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 3.444

9.  Rapid mitochondrial dysfunction mediates TNF-alpha-induced neurotoxicity.

Authors:  Danielle N Doll; Stephanie L Rellick; Taura L Barr; Xuefang Ren; James W Simpkins
Journal:  J Neurochem       Date:  2015-01-29       Impact factor: 5.372

10.  Neuronal I kappa B kinase beta protects mice from autoimmune encephalomyelitis by mediating neuroprotective and immunosuppressive effects in the central nervous system.

Authors:  Mary Emmanouil; Era Taoufik; Vivian Tseveleki; Sotiris-Spyros Vamvakas; Theodore Tselios; Michael Karin; Hans Lassmann; Lesley Probert
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.